Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype–phenotype relationship, and clinical outcome-Reference-Cited by-同舟云学术

Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype–phenotype relationship, and clinical outcome

Published:2014-02-28 Issue:9 Volume:36 Page:560-565
ISSN:1522-9645
Container-title:European Heart Journal
language:en
Short-container-title:

Author:

Sjouke Barbara,Kusters D. Meeike,Kindt Iris,Besseling Joost,Defesche Joep C.,Sijbrands Eric J.G.,Roeters van Lennep Jeanine E.,Stalenhoef Anton F.H.,Wiegman Albert,de Graaf Jacqueline,Fouchier Sigrid W.,Kastelein John J.P.,Hovingh G. Kees

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartj/article-pdf/36/9/560/17356010/ehu058.pdf

Reference33 articles.

1. Familial hypercholesterolemia;Goldstein,2001

2. Longitudinal evaluation and assessment of cardiovascular disease in patients with homozygous familial hypercholesterolemia;Kolansky;Am J Cardiol,2008

3. Efficacy of statins in familial hypercholesterolaemia: a long term cohort study;Versmissen;Br Med J,2008

4. Reduction in mortality in subjects with homozygous familial hypercholesterolemia associated with advances in lipid-lowering therapy;Raal;Circulation,2011

5. ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS);Catapano;Atherosclerosis,2011

Cited by 359 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Consensus document on diagnosis and management of familial hypercholesterolemia from the Italian Society for the Study of Atherosclerosis (SISA);Nutrition, Metabolism and Cardiovascular Diseases;2024-08

2. Detecting familial hypercholesterolemia: An observational study leveraging mandatory universal pediatric total cholesterol screening in Slovakia;Journal of Clinical Lipidology;2024-07

3. Lomitapide: A Medication Use Evaluation and a Formulary Perspective;Global Journal on Quality and Safety in Healthcare;2024-05-01

4. Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia;JAMA Cardiology;2024-04-01

5. Sex differences in the presentation, treatment and outcomes of patients with homozygous familial hypercholesterolemia;Journal of Clinical Lipidology;2024-03